We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




A Better Way to Grow Stem Cells

By LabMedica International staff writers
Posted on 30 Aug 2010
An innovative synthetic surface that includes no foreign animal material allows stem cells to stay alive and continue reproducing themselves for at least three months.

Researchers at the Massachusetts Institute of Technology (MIT; Cambridge, USA) wished to create a chemically defined, xeno-free, feeder-free synthetic substrate that could support robust self-renewal of fully dissociated human embryonic stem and induced pluripotent stem cells. More...
To do so, they first created about 500 polymers that differed in the physical properties of their surfaces--including roughness, stiffness, and affinity for water--to find an appropriate material that might play a role in stem-cell growth. The researchers then grew stem cells on each of them and analyzed each polymer's performance. After correlating surface characteristics with performance, they found that there was an optimal range of surface hydrophobicity (water-repelling behavior), but that varying roughness and stiffness did not seem to have much effect on cell growth.

The researchers also adjusted the composition of the materials, including proteins embedded in the polymer, and found that the best polymers contained a high percentage of acrylates (a common ingredient in plastics), had a moderate wettability, and employed integrin αvβ3 and αvβ5 engagement with adsorbed vitronectin to promote proliferation colony formation. Using their best-performing material, the researchers induced both embryonic and pluripotent stem cells to continue growing and dividing for up to three months. They were also able to generate large quantities of cells, numbering in the millions. The study was published in the August 22, 2010, issue of Nature Materials.

"For therapeutics, you need millions and millions of cells,” said lead author Krishanu Saha, Ph.D., of the department of chemical engineering. "If we can make it easier for the cells to divide and grow, that will really help to get the number of cells you need to do all of the disease studies that people are excited about.”

Both human embryonic stem cells and induced pluripotent stem cells can self-renew indefinitely in culture; however, present methods to clonally grow them are inefficient and poorly defined for genetic manipulation and therapeutic purposes, since a layer of mouse cells or proteins are used to stimulate the stem-cell growth; however, these same cells are likely cause an immune reaction if injected into a human patient.

Related Links:
Massachusetts Institute of Technology




Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Blood Ammonia Test Analyzer
DRI-CHEM NX10N
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.